Effect of alogliptin on diabetic vascular complication

Trial Profile

Effect of alogliptin on diabetic vascular complication

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 15 Oct 2015

At a glance

  • Drugs Alogliptin (Primary)
  • Indications Atherosclerosis; Type 2 diabetes mellitus
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 13 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 06 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top